Cytomegalovirus Breakthrough in Pediatric Cardiac Transplant Recipients Receiving Weight-Based Dosing Valganciclovir Prophylaxis
This study's findings suggest implementation of a standard dosing procedure may be useful in optimizing prophylaxis with valganciclovir.
Authors
- Nicole Poirier
- Jessica A. Laks (ORCID: https://orcid.org/0000-0002-4138-2549)
- Amy L. Kiskaddon
- Alfred Asante‐Korang (ORCID: https://orcid.org/0000-0002-3621-2246)
- Alyssa Miles (ORCID: https://orcid.org/0000-0001-6387-7625)
- Asma Khan
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Johns Hopkins All Children's Hospital (US)
- Lurie Children's Hospital (US)
Publication Details
- Journal
- The Journal of Pediatric Pharmacology and Therapeutics
- Published
- 2025-12-01
- DOI
- https://doi.org/10.5863/jppt-24-00148
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00